Experimental Hematology

Herausgeber

Elsevier Science Inc

International Standard Serial Number (ISSN )

0301-472X

ISSN gedruckt

0301-472X

URL

http://www.bibliothek.uni-regensburg.de/ezeit/?2005403

Weitere Details

2024

EFFECTS OF DIFFERENT MUTATIONS CAUSING CLONAL HAEMATOPOIESIS.

2021

CDK6 IN HEMATOPOIETIC STEM CELLS: MORE THAN A CELL CYCLE KINASE

2018

Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph⁺ chronic myeloid leukemia

2010

H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells.

2010

In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V.

2010

KIT polymorphisms and mutations determine responses of neoplastic mast cells to bafetinib (INNO-406).

2008

Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1-PDGFRalpha.

2008

Targeting of heat-shock protein 32/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosis.

2007

STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output.

2007

Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells.

2007

Persistent Stat5 activation supports functional erythropoiesis in the absence of Jak2 and EPOR.

Kenner, Lukas
2014

Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format

2024

EFFECTS OF DIFFERENT MUTATIONS CAUSING CLONAL HAEMATOPOIESIS.

2021

CDK6 IN HEMATOPOIETIC STEM CELLS: MORE THAN A CELL CYCLE KINASE

2018

Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph⁺ chronic myeloid leukemia

2010

H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells.

2010

In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V.

2010

KIT polymorphisms and mutations determine responses of neoplastic mast cells to bafetinib (INNO-406).

2008

Dasatinib inhibits the growth and survival of neoplastic human eosinophils (EOL-1) through targeting of FIP1L1-PDGFRalpha.

2008

Targeting of heat-shock protein 32/heme oxygenase-1 in canine mastocytoma cells is associated with reduced growth and induction of apoptosis.

2007

STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output.

2007

Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells.

2007

Persistent Stat5 activation supports functional erythropoiesis in the absence of Jak2 and EPOR.

Kenner, Lukas
2014

Download
RDF/XML-Format
JSON-LD-Format
Turtle-Format
N3-Format